Key result
Fibroblast-specific IL-1 deletion reduces cardiac inflammation ~45% in acute viral myocarditis without impairing viral clearance.
Effect estimate: 45% reduction
p-value: p=0.013
Fibroblast-specific IL-1 signaling is a critical driver of inflammation in acute viral myocarditis, highlighting inflammatory fibroblasts as a potential therapeutic target.
IL-1 signaling in cardiac fibroblasts represents a potential therapeutic target in viral myocarditis; supports further research but should not yet alter clinical practice.
mice to specifically delete IL-1 signaling in fibroblasts. This targeted deletion reduced total cardiac inflammation by 45%-specifically lowering monocytes, T cells, and NK cells-without affecting viral clearance. By confirming the presence of IFs in endomyocardial biopsies from human patients, we have shown that fibroblast-specific IL-1 signaling is a critical driver of disease and a potential therapeutic target.
No takes yet. Share an insight, caveat, or question.
Elias et al. (2026) studied Acute Coxsackievirus B3 Myocarditis. Fibroblast-specific deletion of IL1r1 vs. Cre control mice was evaluated on Total cardiac inflammation (myocarditis severity) (45% reduction, p=0.013). Targeted deletion of IL-1 signaling in cardiac fibroblasts reduced total cardiac inflammation by 45% during acute Coxsackievirus B3 myocarditis without affecting viral clearance.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: